|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cryptocurrency News Articles
$10M Bitcoin? Saylor Says That's When Financial Advisors Finally Get It
May 02, 2025 at 10:30 am

The price of bitcoin (BTC) could yet soar to seven figures, according to legal and political analysis from Strategy executives.
Pointing to the fact that financial advisors are still largely preventing clients from gaining exposure to bitcoin ETFs, Strategy executive chairman Michael Saylor highlighted the slow rollout of crypto products among wealthy institutions.
"By the time your financial adviser says it’s OK to buy bitcoin, it’ll cost $1 million. When they say it’s a good idea, it’ll be $10 million," Saylor stated on April 30.
Related: Bitcoin futures ETFs 'nowhere in sight' despite optimism - Wisdom Chain's Ben Chain
Breaking down the topic further, the analysis came from a chart published by Tephra Digital, which surveyed the status of bitcoin ETF access at major wealth management firms.
The data, based on direct conversations with advisors in spring 2024, sorted ETF access into three categories: prohibited, restricted, and unrestricted. Of the total estimated assets under management, about 38% are housed in firms offering full access to bitcoin ETFs.
This includes platforms like Charles Schwab, Fidelity, and Wells Fargo, which together offer exposure to nearly $19.1 trillion in funds.
However, approximately $20.9 trillion is tied to platforms with restricted access, which includes conditions based on account type, exposure limits, or investor eligibility.
Another $10.3 trillion is completely cut off from ETF access, with platforms like Vanguard, Edward Jones, and Citi continuing to bar any exposure to bitcoin ETFs.
Potential capital flows were also highlighted by Tephra Digital. If just a 5% allocation to bitcoin ETFs were allowed on platforms currently prohibiting or limiting access, as much as $1.56 trillion could be invested. Even a 1% allocation would account for $312 billion.
While critics highlight market volatility and regulatory concerns, bitcoin supporters argue that dismantling these access barriers could accelerate mainstream institutional adoption. The chart illustrates not only current accessibility but also the scale of unrealized capital that could shift markets if policy positions at these wealth platforms evolve.
Disclaimer:info@kdj.com
The information provided is not trading advice. kdj.com does not assume any responsibility for any investments made based on the information provided in this article. Cryptocurrencies are highly volatile and it is highly recommended that you invest with caution after thorough research!
If you believe that the content used on this website infringes your copyright, please contact us immediately (info@kdj.com) and we will delete it promptly.
-
-
- Datavecta Forges Global Community Ecosystem to Power International Growth Through Advanced SEO Strategy
- Sep 30, 2026 at 07:55 pm
- Datavecta is building a global community ecosystem to enhance international growth, leveraging advanced SEO strategies and technology-driven services for a connected intelligent trading future.
-
- Illinois Rolls Out Draft Rules for 0.2% Crypto Transaction Tax, Set for 2027
- Sep 30, 2026 at 12:05 pm
- Illinois unveils draft regulations for its upcoming 0.2% digital asset transaction tax, impacting exchanges, transfers, and custody services starting January 1, 2027. The tax applies to the gross value of transactions, not investment gains.
-
-
- Apeing Leads the Charge: Unveiling the Next 100x Crypto Watchlist and 6 Coins to Eye
- Sep 30, 2026 at 12:03 pm
- Amidst a dynamic crypto market, Apeing's presale momentum, coupled with established players like Solana and TRON, is redefining the 100x crypto narrative, offering both early-stage opportunities and proven network strength.
-
-
- OpenAI Unveils GPT-6.1 Sol and Ultrafast Tier, While AstraZeneca Invests Big in Summit Therapeutics
- Sep 30, 2026 at 08:05 am
- OpenAI rolls out GPT-6.1 Sol, offering near-Astra performance at a fraction of the cost, alongside a new 'Ultrafast' speed tier. Meanwhile, AstraZeneca makes a significant $2 billion investment in oncology firm Summit Therapeutics.
-
-
































